Kamdar Kim P.

Director at Singular Genomics Systems, Inc. · on record since May 26, 2021
10% owner at Clovis Oncology, Inc. · on record since Nov 16, 2011
10% owner at ACHILLION PHARMACEUTICALS INC · on record since Jan 17, 2012
10% owner at Orexigen Therapeutics, Inc. · on record since Jan 17, 2012
10% owner at ZOGENIX, INC. · on record since Jan 17, 2012
10% owner at CADENCE PHARMACEUTICALS INC · on record since Jan 17, 2012
10% owner at Durata Therapeutics, Inc. · on record since Jul 18, 2012
10% owner at Celator Pharmaceuticals Inc · on record since Jan 15, 2013
10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
10% owner at Evoke Pharma Inc · on record since Sep 24, 2013
10% owner at Regado Biosciences Inc · on record since Aug 21, 2013
10% owner at TRANZYME INC · on record since Jul 16, 2013
10% owner at Aldeyra Therapeutics, Inc. · on record since May 1, 2014
10% owner at MARINUS PHARMACEUTICALS INC · on record since Jul 31, 2014
Director at OBALON THERAPEUTICS INC · on record since Oct 14, 2016
Director at Neothetics, Inc. · on record since Nov 19, 2014
10% owner at Neothetics, Inc. · on record since Nov 19, 2014
10% owner at GLAUKOS Corp · on record since Jun 24, 2015
10% owner at · on record since May 6, 2015
Director at · on record since Mar 2, 2016
10% owner at · on record since Mar 2, 2016
10% owner at · on record since Aug 21, 2018
Director at · on record since Jul 14, 2021

Insider trading activity of Kamdar Kim P.

Transactions on record: 59; since Mar 21, 2014

Open-market buys: 5; $377.4K

Open-market sells: 5; $366K

Companies traded: 7; last filing Jul 14, 2026

Figures computed from official regulatory filings — .

Companies where Kamdar Kim P. has traded

12 tx · Jul 14, 2026
17 tx · $384.4K · Feb 25, 2025
17 tx · $29.7K · Dec 22, 2023
10 tx · $388.5K · Sep 18, 2020
1 tx · Nov 2, 2016
1 tx · Nov 18, 2014
1 tx · $385K · Mar 21, 2014

Track record of Kamdar Kim P.

Statistical track record

Free

Open-market buys: 6

Last buy: Jun 18, 2021

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Kamdar Kim P.

Co-insiders of Kamdar Kim P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
SERA PROGNOSTICS, INC.	Jul 14, 2026	Award	3,421	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jul 14, 2026	Award	22,426	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jul 14, 2026	AwardD (derivative)	5,263	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jul 14, 2026	AwardD (derivative)	34,494	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Feb 4, 2026	Other	-30,920	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Feb 4, 2026	Other	3,231	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 6, 2025	AwardD (derivative)	25,000	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 6, 2025	Award	15,596	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	Other	-15,000	—	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	Other	-3,763,985	—	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-2,466	8.84 USD	$21.8K	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-1,541	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-666	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	Other	-15,000	—	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-2,466	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 7, 2024	AwardD (derivative)	10,549	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 7, 2024	Award	7,117	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	May 31, 2024	AwardD (derivative)	74,000	0.00 USD	—	SEC
Neothetics, Inc.	Dec 22, 2023	Sell	-10	0.62 USD	$6.2	SEC
Singular Genomics Systems, Inc.	Aug 15, 2023	Sell	-77,991	0.57 USD	$44.5K	SEC
Singular Genomics Systems, Inc.	Aug 15, 2023	Sell	-353,657	0.60 USD	$212.2K	SEC
Singular Genomics Systems, Inc.	Aug 15, 2023	Sell	-200,000	0.53 USD	$106K	SEC
SERA PROGNOSTICS, INC.	Jul 7, 2023	AwardD (derivative)	63,265	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	May 26, 2023	AwardD (derivative)	74,000	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 6, 2022	AwardD (derivative)	149,675	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
SERA PROGNOSTICS, INC.	Jul 14, 2026	Award	3,421	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jul 14, 2026	Award	22,426	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jul 14, 2026	AwardD (derivative)	5,263	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jul 14, 2026	AwardD (derivative)	34,494	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Feb 4, 2026	Other	-30,920	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Feb 4, 2026	Other	3,231	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 6, 2025	AwardD (derivative)	25,000	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 6, 2025	Award	15,596	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	Other	-15,000	—	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	Other	-3,763,985	—	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-2,466	8.84 USD	$21.8K	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-1,541	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-666	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	Other	-15,000	—	—	SEC
Singular Genomics Systems, Inc.	Feb 25, 2025	OtherD (derivative)	-2,466	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 7, 2024	AwardD (derivative)	10,549	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 7, 2024	Award	7,117	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	May 31, 2024	AwardD (derivative)	74,000	0.00 USD	—	SEC
Neothetics, Inc.	Dec 22, 2023	Sell	-10	0.62 USD	$6.2	SEC
Singular Genomics Systems, Inc.	Aug 15, 2023	Sell	-77,991	0.57 USD	$44.5K	SEC
Singular Genomics Systems, Inc.	Aug 15, 2023	Sell	-353,657	0.60 USD	$212.2K	SEC
Singular Genomics Systems, Inc.	Aug 15, 2023	Sell	-200,000	0.53 USD	$106K	SEC
SERA PROGNOSTICS, INC.	Jul 7, 2023	AwardD (derivative)	63,265	0.00 USD	—	SEC
Singular Genomics Systems, Inc.	May 26, 2023	AwardD (derivative)	74,000	0.00 USD	—	SEC
SERA PROGNOSTICS, INC.	Jun 6, 2022	AwardD (derivative)	149,675	0.00 USD	—	SEC